triphosphoric acid and sorafenib

triphosphoric acid has been researched along with sorafenib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Alam, MF; Elmobark, ME; Makeen, HA; Moni, SS; Safhi, MM; Sultan, MH	1
Albalawi, F; Fakurazi, S; Hussein, MZ; Masarudin, MJ	1

Other Studies

2 other study(ies) available for triphosphoric acid and sorafenib

Article	Year
Development of Formulation Methods and Physical Characterization of Injectable Sodium Selenite Nanoparticles for the Delivery of Sorafenib tosylate. Current pharmaceutical biotechnology, 2020, Volume: 21, Issue:8 Topics: Antineoplastic Agents; Cross-Linking Reagents; Drug Carriers; Drug Compounding; Humans; Nanoparticles; Particle Size; Polyphosphates; Sodium Selenite; Sorafenib; Surface Properties	2020
Fabrication and characterization of nanodelivery platform based on chitosan to improve the anticancer outcome of sorafenib in hepatocellular carcinoma. Scientific reports, 2023, 07-27, Volume: 13, Issue:1 Topics: Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Humans; Liver Neoplasms; Nanoparticles; Sorafenib	2023

Article

Year

Development of Formulation Methods and Physical Characterization of Injectable Sodium Selenite Nanoparticles for the Delivery of Sorafenib tosylate.

Current pharmaceutical biotechnology, 2020, Volume: 21, Issue:8

Topics: Antineoplastic Agents; Cross-Linking Reagents; Drug Carriers; Drug Compounding; Humans; Nanoparticles; Particle Size; Polyphosphates; Sodium Selenite; Sorafenib; Surface Properties

2020

Fabrication and characterization of nanodelivery platform based on chitosan to improve the anticancer outcome of sorafenib in hepatocellular carcinoma.

Scientific reports, 2023, 07-27, Volume: 13, Issue:1

Topics: Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Humans; Liver Neoplasms; Nanoparticles; Sorafenib

2023